Marie-Cécile Blanchet1,2, Benoît Gignoux3, Yann Matussière3,4, Alexandre Vulliez3,5, Thomas Lanz3,5, Fabienne Monier3,5, Vincent Frering3. 1. Clinique de la Sauvegarde, Lyon, France. blanchet@chirurgien-digestif.com. 2. Espace Médico-Chirurgical, Immeuble ''Trait d'Union'', Entrée A29 Av des Sources, 69009, Lyon, France. blanchet@chirurgien-digestif.com. 3. Clinique de la Sauvegarde, Lyon, France. 4. Department of Nutrition 29 avenue des Sources- Clinique de la Sauvegarde, 69009, Lyon, France. 5. Department of anesthesiology - 29 avenue des Sources- Clinique de la Sauvegarde, 69009, Lyon, France.
Abstract
BACKGROUND: Strategic multidisciplinary protocols for "enhanced recovery after surgery" (ERAS) have demonstrated reductions in length of hospital stay (LOS), morbidity, and costs in conjunction with bariatric procedures. METHODS: We prospectively investigated the effectiveness and safety of an ERAS protocol with laparoscopic omega loop gastric bypass ("mini" gastric bypass, MGB) and LSG in morbidly obese patients. RESULTS: Average LOS was 1.24 days (range 1-14); 86.1% discharged on day 1; 96.9% by day 2, a value comparable or better than that of other ERAS studies vs standard care according to meta-analysis. Complications 2.9%; readmission 2.1%; reintervention 1.3%. CONCLUSION: The program was equally safe with both procedures. Postoperative antithrombotic heparin does not appear necessary in low-risk patients. Bariatric surgical ERAS programs are evolving and not yet standardized.
BACKGROUND: Strategic multidisciplinary protocols for "enhanced recovery after surgery" (ERAS) have demonstrated reductions in length of hospital stay (LOS), morbidity, and costs in conjunction with bariatric procedures. METHODS: We prospectively investigated the effectiveness and safety of an ERAS protocol with laparoscopic omega loop gastric bypass ("mini" gastric bypass, MGB) and LSG in morbidly obesepatients. RESULTS: Average LOS was 1.24 days (range 1-14); 86.1% discharged on day 1; 96.9% by day 2, a value comparable or better than that of other ERAS studies vs standard care according to meta-analysis. Complications 2.9%; readmission 2.1%; reintervention 1.3%. CONCLUSION: The program was equally safe with both procedures. Postoperative antithrombotic heparin does not appear necessary in low-risk patients. Bariatric surgical ERAS programs are evolving and not yet standardized.
Authors: Guido H H Mannaerts; Stefanie R van Mil; Pieter S Stepaniak; Martin Dunkelgrün; Marcel de Quelerij; Serge J Verbrugge; Hans F Zengerink; L Ulas Biter Journal: Obes Surg Date: 2016-02 Impact factor: 4.129
Authors: A Thorell; A D MacCormick; S Awad; N Reynolds; D Roulin; N Demartines; M Vignaud; A Alvarez; P M Singh; D N Lobo Journal: World J Surg Date: 2016-09 Impact factor: 3.352
Authors: Zhamak Khorgami; Jacob A Petrosky; Amin Andalib; Ali Aminian; Philip R Schauer; Stacy A Brethauer Journal: Surg Obes Relat Dis Date: 2016-02-02 Impact factor: 4.734
Authors: Andrea T Obi; Christopher J Pannucci; Andrew Nackashi; Newaj Abdullah; Rafael Alvarez; Vinita Bahl; Thomas W Wakefield; Peter K Henke Journal: JAMA Surg Date: 2015-10 Impact factor: 14.766
Authors: D P Lemanu; P P Singh; K Berridge; M Burr; C Birch; R Babor; A D MacCormick; B Arroll; A G Hill Journal: Br J Surg Date: 2013-01-21 Impact factor: 6.939
Authors: Robert Rutledge; Mervyn Deitel; Miguel A Carbajo; Enrique Luque-de-Leon; Sonja Chiappetta; Aatif Inam; Karl Rheinwalt; Arun Prasad; David E Hargroder; Vladimir Samoylov; M Mahir Ozmen; Chetan Parmar; António Albuquerque; Gurvinder Jammu; Murat Ustun; Nasser Sakran; Recep Aktimur; Amir Khan; Yasser Hamza; Adriana Rotundo; Marc Focquet; Michael Van den Bossche; Om Tantia; Francesco Greco; Midhat Abu Sneineh; Francisco Barrera Rodriguez; Mario Musella; Miroslav Ilić; Imran Abbas Journal: Obes Surg Date: 2020-02 Impact factor: 4.129
Authors: Maurizio De Luca; Tiffany Tie; Geraldine Ooi; Kelvin Higa; Jacques Himpens; Miguel-A Carbajo; Kamal Mahawar; Scott Shikora; Wendy A Brown Journal: Obes Surg Date: 2018-05 Impact factor: 4.129
Authors: Marjolijn Leeman; Jeannine Huisbrink; Julie M A Wijnand; L Ulas Biter; Serge J C Verbrugge; Martin Dunkelgrun; Jan A Apers Journal: BMJ Open Date: 2020-02-05 Impact factor: 2.692
Authors: Mohamed Ibrahim; Ali M Elnabtity; Ahmed Hegab; Omar A Alnujaidi; Osama El Sanea Journal: BMC Anesthesiol Date: 2022-01-21 Impact factor: 2.217